About AM Technology

AM Technology was founded in 2000. The company specialises in innovative solutions for the manufacture of high value chemicals. AM Technology is the global leader in CSTR technology for continuous synthesis of high value chemicals. Our products are protected by global patents and are used in the manufacture of fine chemicals, pharmaceuticals, flavours and fragrances, dyes, polymers and bio synthesis. Our customers include manufacturers, universities and research groups.

Our reactor products are designed to allow full manufacturing scale-up of lab scale processes, allowing our customers to be sure their research effort translates directly into production capability. We offer a range of standard lab units for process development and industrial scale flow reactors in a variety of materials. Specialised systems can be built to customer requirements and can be supplied as basic reactor units or fully integrated systems. We provide customers with a wealth of knowledge to support the development and scale up of their flow processes.

Current Projects

Nano-enabled Peptide Pill

Partners - Nanomerics, UCL School of Pharmacy, University of Exeter
Funding - £1.6M co-funded by the UK Technology Stratergy Board (TSB)
Objectives - Develop the supply chain for polymer based nanoparticles for drug delivery to teh brain barriers

Investigation of catalytic hydrogenation using Coflore continuous processing technology

Partners – Fine Organics Ltd
Funding – £ 73k co-funded by the UK Technology Strategy Board (TSB)

Dynamically mixed multi-phase flow hydrogenation

Partners – Robinson Brothers Ltd
Funding – £ 99k co-funded by the UK Technology Strategy Board (TSB)

Manufacture of Chiral Amines using Catalytic and Flow Methods

Partners – YPT, AZ, Syngenta, Chirotech, Pfizer, Leeds University, University of Liverpool
Funding – £ 1.1M co-funded by the UK Technology Strategy Board (TSB)

Past Projects

Pharmagen

Partners – Serichim (project coordinator, IT), Flamma (IT), Merchav (IL), Carbopharm (AT), PSE (GB), LDT (IT), AM Technology (GB)
Funding – € 1,041,612 Co funded by the European Commision (FP7)
Objectives – The development and scale up of continuous solutions for the manufacture of active pharmaceutical ingredients (APIs)
Website - http://www.pharmagen-project.eu/

Biochemist

Partners – Ingenza, C-Tech
Funding – £ 1,1018,274 Co funded by the Technology Strategy Board
Objectives – Develop new methods of continuous synthesis for Biopharmaceutical products
Website - http://biochemistproject.com/

CCrystal

Partners – AM Technology (project coordinator, GB), Flamma (IT), Merchav (IL), Galentis (IT), Serichim (IT), Autico (GB), PSE (GB), LDT (IT)
Funding – € 1,105,500 Co funded by the European Communion (FP7)
Objectives – Develop new methods of continuous crystallisation

Biopress

Partners - Ingenza, C-Tech
Funding - £200,000 Co-funded by the UK Technology Stratergy Board (TSB)
Objectives - Develop a high pressure process for the process intensification of a biocatalytic oxidase process